---
schema_version: "secwatch.filing_event.v1"
accession: "0001683168-22-001119"
form_type: "8-K"
ticker: "PMCB"
cik: "0001157075"
company_name: "PharmaCyte Biotech, Inc."
filed_at: "2022-02-17T23:59:59+00:00"
generated_at: "2026-06-27T06:55:00.858017+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pharmacyte Biotech notifies Nasdaq of board independence non-compliance after director death

## Summary
- Board member Thomas C.K. Yuen died Feb 13, 2022; company notified Nasdaq Feb 15, 2022.
- Due to his death, majority of board no longer independent, violating Nasdaq Listing Rule 5605(b)(1).
- Company has automatic cure period; expects to regain compliance by appointing new independent director.

## SEC filing metadata
- accession: 0001683168-22-001119
- form_type: 8-K
- ticker: PMCB
- cik: 0001157075
- company_name: PharmaCyte Biotech, Inc.
- filed_at: 2022-02-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/0001683168-22-001119-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1157075/000168316822001119/pharmacyte_i8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001683168-22-001119
- JSON: https://secwatch.observer/filing/0001683168-22-001119.json
- Plain text: https://secwatch.observer/filing/0001683168-22-001119.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.